Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Stomach Neoplasms | 24 | 2021 | 1459 | 2.210 |
Why?
|
Polymorphism, Single Nucleotide | 62 | 2021 | 15941 | 1.800 |
Why?
|
Colorectal Neoplasms | 31 | 2021 | 6935 | 1.260 |
Why?
|
MicroRNAs | 17 | 2021 | 3812 | 1.200 |
Why?
|
Urinary Bladder Neoplasms | 12 | 2021 | 2223 | 0.900 |
Why?
|
Genetic Predisposition to Disease | 43 | 2021 | 17912 | 0.850 |
Why?
|
Body Fluids | 1 | 2021 | 320 | 0.640 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 362 | 0.610 |
Why?
|
China | 18 | 2021 | 2366 | 0.590 |
Why?
|
Case-Control Studies | 42 | 2021 | 22168 | 0.550 |
Why?
|
Gene Expression Regulation, Neoplastic | 17 | 2021 | 8545 | 0.510 |
Why?
|
Genetic Association Studies | 10 | 2021 | 2734 | 0.450 |
Why?
|
Promoter Regions, Genetic | 12 | 2020 | 5789 | 0.440 |
Why?
|
Genome-Wide Association Study | 23 | 2021 | 12688 | 0.430 |
Why?
|
Genotype | 27 | 2021 | 13009 | 0.410 |
Why?
|
Quantitative Trait Loci | 11 | 2021 | 2116 | 0.410 |
Why?
|
Genetic Variation | 11 | 2021 | 6581 | 0.390 |
Why?
|
Particulate Matter | 8 | 2021 | 2595 | 0.380 |
Why?
|
Gastrointestinal Diseases | 1 | 2020 | 1199 | 0.380 |
Why?
|
Adenosine | 3 | 2021 | 808 | 0.380 |
Why?
|
Alleles | 14 | 2020 | 6922 | 0.330 |
Why?
|
Homeodomain Proteins | 2 | 2015 | 2416 | 0.320 |
Why?
|
Prognosis | 28 | 2021 | 29620 | 0.310 |
Why?
|
Carcinoma, Papillary | 1 | 2014 | 785 | 0.310 |
Why?
|
DNA Methylation | 7 | 2021 | 4391 | 0.290 |
Why?
|
ROC Curve | 8 | 2021 | 3580 | 0.280 |
Why?
|
Carcinoma, Renal Cell | 3 | 2020 | 3163 | 0.270 |
Why?
|
Area Under Curve | 5 | 2021 | 1638 | 0.270 |
Why?
|
CpG Islands | 3 | 2020 | 1229 | 0.270 |
Why?
|
DNA Damage | 4 | 2020 | 2446 | 0.270 |
Why?
|
Organic Cation Transport Proteins | 2 | 2019 | 61 | 0.270 |
Why?
|
RNA, Small Interfering | 3 | 2021 | 3428 | 0.260 |
Why?
|
Kidney Neoplasms | 3 | 2020 | 4248 | 0.250 |
Why?
|
Endonucleases | 2 | 2020 | 371 | 0.240 |
Why?
|
Humans | 106 | 2021 | 761423 | 0.230 |
Why?
|
Middle Aged | 53 | 2021 | 220826 | 0.220 |
Why?
|
Survival Analysis | 13 | 2021 | 10089 | 0.220 |
Why?
|
Male | 70 | 2021 | 360736 | 0.220 |
Why?
|
Tumor Suppressor Proteins | 3 | 2020 | 2803 | 0.220 |
Why?
|
Female | 70 | 2021 | 392581 | 0.210 |
Why?
|
Colonic Neoplasms | 3 | 2021 | 2538 | 0.200 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3082 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3202 | 0.200 |
Why?
|
Databases, Genetic | 4 | 2021 | 1742 | 0.190 |
Why?
|
3' Untranslated Regions | 4 | 2018 | 519 | 0.190 |
Why?
|
Air Pollutants | 3 | 2020 | 2881 | 0.190 |
Why?
|
Neoplasm Staging | 10 | 2020 | 11106 | 0.190 |
Why?
|
Nomograms | 2 | 2020 | 230 | 0.190 |
Why?
|
Dichlorodiphenyl Dichloroethylene | 1 | 2021 | 86 | 0.180 |
Why?
|
DNA Primase | 1 | 2021 | 110 | 0.180 |
Why?
|
17-Hydroxysteroid Dehydrogenases | 1 | 2020 | 56 | 0.180 |
Why?
|
Aged | 39 | 2021 | 169235 | 0.180 |
Why?
|
Glucuronosyltransferase | 1 | 2021 | 132 | 0.180 |
Why?
|
Cell Line, Tumor | 11 | 2021 | 16979 | 0.180 |
Why?
|
Cardia | 1 | 2020 | 60 | 0.180 |
Why?
|
Cell Proliferation | 8 | 2020 | 10441 | 0.180 |
Why?
|
Lung Neoplasms | 6 | 2021 | 13337 | 0.170 |
Why?
|
Gene Frequency | 8 | 2021 | 3647 | 0.170 |
Why?
|
Sialoglycoproteins | 1 | 2021 | 316 | 0.170 |
Why?
|
Secretory Pathway | 1 | 2020 | 54 | 0.170 |
Why?
|
Gastric Acid | 1 | 2020 | 99 | 0.170 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2021 | 233 | 0.170 |
Why?
|
Biosynthetic Pathways | 1 | 2020 | 136 | 0.170 |
Why?
|
GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2020 | 89 | 0.170 |
Why?
|
Gene Expression Profiling | 7 | 2020 | 9418 | 0.170 |
Why?
|
Light Coagulation | 1 | 2019 | 72 | 0.170 |
Why?
|
Signal Transduction | 11 | 2021 | 23441 | 0.170 |
Why?
|
Glaucoma, Neovascular | 1 | 2019 | 37 | 0.170 |
Why?
|
Sequence Analysis, RNA | 2 | 2017 | 2020 | 0.170 |
Why?
|
5-Methylcytosine | 1 | 2020 | 148 | 0.170 |
Why?
|
Laminin | 1 | 2021 | 408 | 0.170 |
Why?
|
Pseudogenes | 1 | 2019 | 104 | 0.160 |
Why?
|
Replication Protein A | 1 | 2019 | 53 | 0.160 |
Why?
|
Cation Transport Proteins | 1 | 2021 | 327 | 0.160 |
Why?
|
Phosphoinositide Phospholipase C | 1 | 2018 | 29 | 0.160 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2020 | 332 | 0.160 |
Why?
|
Xanthine Dehydrogenase | 1 | 2018 | 18 | 0.160 |
Why?
|
Glucosylceramidase | 1 | 2019 | 127 | 0.150 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2018 | 49 | 0.150 |
Why?
|
Glaucoma Drainage Implants | 1 | 2019 | 107 | 0.150 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2021 | 350 | 0.150 |
Why?
|
Lectins, C-Type | 1 | 2021 | 584 | 0.150 |
Why?
|
Catalase | 1 | 2018 | 218 | 0.150 |
Why?
|
Platinum Compounds | 1 | 2018 | 95 | 0.150 |
Why?
|
RNA, Neoplasm | 1 | 2021 | 750 | 0.150 |
Why?
|
Superoxide Dismutase | 1 | 2020 | 594 | 0.150 |
Why?
|
Riboflavin | 1 | 2018 | 107 | 0.150 |
Why?
|
Sulfotransferases | 1 | 2018 | 150 | 0.140 |
Why?
|
Glutathione Peroxidase | 1 | 2018 | 258 | 0.140 |
Why?
|
Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2017 | 21 | 0.140 |
Why?
|
Eukaryotic Initiation Factor-4E | 1 | 2018 | 113 | 0.140 |
Why?
|
Down-Regulation | 3 | 2020 | 2918 | 0.140 |
Why?
|
Risk Factors | 20 | 2021 | 74167 | 0.140 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 2017 | 120 | 0.140 |
Why?
|
Air Pollution | 2 | 2020 | 2348 | 0.140 |
Why?
|
Autophagy | 2 | 2021 | 1326 | 0.140 |
Why?
|
Betaine | 1 | 2016 | 90 | 0.140 |
Why?
|
Helicobacter Infections | 1 | 2020 | 388 | 0.130 |
Why?
|
Phenotype | 6 | 2020 | 16606 | 0.130 |
Why?
|
Computational Biology | 5 | 2021 | 3517 | 0.130 |
Why?
|
Chromosomes, Human, Pair 6 | 2 | 2019 | 375 | 0.130 |
Why?
|
Cyclophilins | 1 | 2016 | 48 | 0.130 |
Why?
|
Circadian Clocks | 1 | 2018 | 164 | 0.130 |
Why?
|
Algorithms | 5 | 2021 | 14026 | 0.130 |
Why?
|
Gonadal Steroid Hormones | 1 | 2020 | 702 | 0.130 |
Why?
|
Vitamin B Complex | 1 | 2018 | 299 | 0.130 |
Why?
|
Risk | 9 | 2018 | 9612 | 0.130 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2016 | 1551 | 0.130 |
Why?
|
DNA Glycosylases | 1 | 2016 | 125 | 0.130 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2016 | 4575 | 0.130 |
Why?
|
Survival Rate | 7 | 2021 | 12720 | 0.130 |
Why?
|
Tea | 1 | 2017 | 288 | 0.130 |
Why?
|
Dietary Supplements | 3 | 2018 | 3414 | 0.130 |
Why?
|
Metabolic Networks and Pathways | 1 | 2020 | 789 | 0.120 |
Why?
|
Cell Adhesion Molecules | 1 | 2021 | 1600 | 0.120 |
Why?
|
Mucin-1 | 1 | 2020 | 540 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2016 | 314 | 0.120 |
Why?
|
Prosthesis Implantation | 1 | 2019 | 592 | 0.120 |
Why?
|
Digestive System Neoplasms | 1 | 2015 | 82 | 0.120 |
Why?
|
Blood Cells | 1 | 2017 | 305 | 0.120 |
Why?
|
Nephrectomy | 1 | 2020 | 937 | 0.120 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2016 | 386 | 0.120 |
Why?
|
Choline | 1 | 2016 | 515 | 0.120 |
Why?
|
Binding Sites | 3 | 2018 | 6055 | 0.120 |
Why?
|
MAP Kinase Signaling System | 1 | 2021 | 1486 | 0.120 |
Why?
|
Kaplan-Meier Estimate | 6 | 2021 | 6479 | 0.120 |
Why?
|
Follow-Up Studies | 10 | 2020 | 39117 | 0.120 |
Why?
|
Nephrolithiasis | 1 | 2016 | 116 | 0.120 |
Why?
|
Quantitative Trait, Heritable | 1 | 2017 | 543 | 0.110 |
Why?
|
Epigenomics | 1 | 2020 | 942 | 0.110 |
Why?
|
Exosomes | 1 | 2018 | 424 | 0.110 |
Why?
|
Oxidoreductases | 1 | 2016 | 413 | 0.110 |
Why?
|
Adenocarcinoma | 3 | 2017 | 6339 | 0.110 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2019 | 2916 | 0.110 |
Why?
|
Anticarcinogenic Agents | 1 | 2015 | 250 | 0.110 |
Why?
|
Caspase 8 | 1 | 2014 | 190 | 0.110 |
Why?
|
Gastric Mucosa | 1 | 2016 | 604 | 0.110 |
Why?
|
Fas Ligand Protein | 1 | 2014 | 216 | 0.110 |
Why?
|
Fluorouracil | 1 | 2018 | 1639 | 0.110 |
Why?
|
Feces | 1 | 2020 | 1497 | 0.110 |
Why?
|
Up-Regulation | 2 | 2021 | 4124 | 0.110 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2021 | 5302 | 0.100 |
Why?
|
Urinary Bladder | 2 | 2020 | 1152 | 0.100 |
Why?
|
Protein Isoforms | 1 | 2017 | 1699 | 0.100 |
Why?
|
Fatty Acids | 1 | 2020 | 1808 | 0.100 |
Why?
|
RNA Splicing | 1 | 2017 | 918 | 0.100 |
Why?
|
Urologic Neoplasms | 1 | 2016 | 314 | 0.100 |
Why?
|
Single-Cell Analysis | 2 | 2021 | 2449 | 0.100 |
Why?
|
Receptors, Cell Surface | 1 | 2021 | 2821 | 0.100 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 382 | 0.100 |
Why?
|
RNA-Binding Proteins | 1 | 2021 | 1897 | 0.100 |
Why?
|
Epigenesis, Genetic | 3 | 2020 | 3798 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 368 | 0.100 |
Why?
|
Sequence Analysis, DNA | 2 | 2020 | 4741 | 0.100 |
Why?
|
Ribonuclease III | 1 | 2013 | 279 | 0.100 |
Why?
|
BRCA2 Protein | 1 | 2016 | 805 | 0.100 |
Why?
|
Mendelian Randomization Analysis | 3 | 2021 | 1008 | 0.090 |
Why?
|
Lymphatic Metastasis | 2 | 2018 | 2914 | 0.090 |
Why?
|
Estrogens | 1 | 2018 | 1522 | 0.090 |
Why?
|
Environmental Exposure | 4 | 2020 | 4467 | 0.090 |
Why?
|
Odds Ratio | 6 | 2020 | 9645 | 0.090 |
Why?
|
Transcription Factors | 3 | 2016 | 12125 | 0.090 |
Why?
|
Risk Assessment | 7 | 2020 | 23990 | 0.090 |
Why?
|
Aged, 80 and over | 9 | 2020 | 58956 | 0.090 |
Why?
|
Dendritic Cells | 1 | 2021 | 2746 | 0.090 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 857 | 0.090 |
Why?
|
Adult | 18 | 2021 | 221148 | 0.090 |
Why?
|
Adenosine Triphosphatases | 1 | 2014 | 834 | 0.090 |
Why?
|
Proteomics | 2 | 2020 | 3845 | 0.080 |
Why?
|
Meta-Analysis as Topic | 1 | 2014 | 1377 | 0.080 |
Why?
|
Early Diagnosis | 1 | 2014 | 1186 | 0.080 |
Why?
|
Bayes Theorem | 1 | 2017 | 2328 | 0.080 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2014 | 727 | 0.080 |
Why?
|
Intestinal Mucosa | 1 | 2020 | 3030 | 0.080 |
Why?
|
Genomics | 3 | 2020 | 5820 | 0.080 |
Why?
|
Gene Regulatory Networks | 1 | 2017 | 1743 | 0.080 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2018 | 2863 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2019 | 3639 | 0.080 |
Why?
|
Folic Acid | 1 | 2015 | 1323 | 0.080 |
Why?
|
Peptide Fragments | 1 | 2021 | 5115 | 0.080 |
Why?
|
Gene Expression Regulation | 3 | 2021 | 11902 | 0.080 |
Why?
|
Genome, Human | 2 | 2019 | 4425 | 0.080 |
Why?
|
Cisplatin | 1 | 2014 | 1650 | 0.080 |
Why?
|
Proportional Hazards Models | 5 | 2021 | 12456 | 0.080 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 3874 | 0.070 |
Why?
|
RNA, Messenger | 6 | 2020 | 12796 | 0.070 |
Why?
|
Postoperative Complications | 2 | 2020 | 15650 | 0.070 |
Why?
|
Models, Biological | 2 | 2021 | 9469 | 0.070 |
Why?
|
Overweight | 1 | 2018 | 2413 | 0.070 |
Why?
|
HCT116 Cells | 2 | 2018 | 404 | 0.070 |
Why?
|
Body Mass Index | 2 | 2021 | 12951 | 0.070 |
Why?
|
Polymerase Chain Reaction | 1 | 2015 | 6086 | 0.070 |
Why?
|
Repressor Proteins | 1 | 2016 | 2985 | 0.060 |
Why?
|
Comet Assay | 2 | 2015 | 75 | 0.060 |
Why?
|
Neoplasm Invasiveness | 3 | 2020 | 3589 | 0.060 |
Why?
|
Apoptosis | 3 | 2019 | 9488 | 0.060 |
Why?
|
Histones | 1 | 2015 | 2580 | 0.060 |
Why?
|
Polymorphism, Genetic | 1 | 2014 | 4287 | 0.060 |
Why?
|
Tandem Mass Spectrometry | 2 | 2021 | 1188 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2019 | 5305 | 0.060 |
Why?
|
Neoplasm Transplantation | 2 | 2018 | 2016 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2020 | 7856 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2017 | 2892 | 0.050 |
Why?
|
Genetic Loci | 3 | 2020 | 2631 | 0.050 |
Why?
|
Smoking | 1 | 2019 | 9052 | 0.050 |
Why?
|
Asthma | 1 | 2021 | 6211 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2017 | 4021 | 0.050 |
Why?
|
Neoplasms | 3 | 2021 | 22164 | 0.050 |
Why?
|
DDT | 1 | 2021 | 32 | 0.050 |
Why?
|
Mice, Inbred BALB C | 2 | 2021 | 6215 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11740 | 0.050 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 1 | 2021 | 77 | 0.050 |
Why?
|
Prostatic Neoplasms | 2 | 2021 | 11118 | 0.050 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein Group C | 1 | 2020 | 16 | 0.050 |
Why?
|
Prospective Studies | 4 | 2021 | 54415 | 0.050 |
Why?
|
Particle Size | 2 | 2015 | 1646 | 0.050 |
Why?
|
YY1 Transcription Factor | 1 | 2020 | 60 | 0.040 |
Why?
|
DNA-Binding Proteins | 2 | 2014 | 9606 | 0.040 |
Why?
|
Regression Analysis | 2 | 2021 | 6343 | 0.040 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2021 | 353 | 0.040 |
Why?
|
Mice | 7 | 2021 | 81509 | 0.040 |
Why?
|
Neoplasm Metastasis | 3 | 2016 | 4912 | 0.040 |
Why?
|
Mutation | 3 | 2020 | 30045 | 0.040 |
Why?
|
Animals | 10 | 2021 | 168441 | 0.040 |
Why?
|
Transcriptional Elongation Factors | 1 | 2021 | 165 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8641 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2020 | 205 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5794 | 0.040 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2020 | 208 | 0.040 |
Why?
|
HT29 Cells | 1 | 2019 | 193 | 0.040 |
Why?
|
Databases, Nucleic Acid | 1 | 2020 | 205 | 0.040 |
Why?
|
Computer Simulation | 3 | 2018 | 6238 | 0.040 |
Why?
|
Computers | 1 | 2021 | 594 | 0.040 |
Why?
|
Platelet Function Tests | 1 | 2020 | 272 | 0.040 |
Why?
|
Likelihood Functions | 1 | 2021 | 992 | 0.040 |
Why?
|
Nasopharynx | 1 | 2021 | 401 | 0.040 |
Why?
|
Molecular Epidemiology | 1 | 2020 | 469 | 0.040 |
Why?
|
Response Elements | 1 | 2019 | 309 | 0.040 |
Why?
|
Epidemiologic Studies | 1 | 2021 | 675 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2018 | 3779 | 0.040 |
Why?
|
Genes, Dominant | 1 | 2020 | 863 | 0.040 |
Why?
|
Platelet Count | 1 | 2020 | 782 | 0.040 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2020 | 615 | 0.040 |
Why?
|
Models, Genetic | 2 | 2018 | 3446 | 0.040 |
Why?
|
Preoperative Period | 1 | 2019 | 552 | 0.040 |
Why?
|
Methylation | 1 | 2020 | 1083 | 0.040 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2020 | 416 | 0.040 |
Why?
|
Vitamin E | 1 | 2021 | 872 | 0.030 |
Why?
|
Genes, Reporter | 1 | 2020 | 1529 | 0.030 |
Why?
|
Cell Movement | 2 | 2019 | 5203 | 0.030 |
Why?
|
RNA Stability | 1 | 2018 | 329 | 0.030 |
Why?
|
History, 17th Century | 1 | 2016 | 108 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2020 | 983 | 0.030 |
Why?
|
Cohort Studies | 4 | 2021 | 41446 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20556 | 0.030 |
Why?
|
Lysosomes | 1 | 2021 | 923 | 0.030 |
Why?
|
Databases, Factual | 2 | 2021 | 7956 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2020 | 1171 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2019 | 749 | 0.030 |
Why?
|
Obesity | 1 | 2018 | 12938 | 0.030 |
Why?
|
Incidence | 3 | 2019 | 21341 | 0.030 |
Why?
|
Gene Expression | 2 | 2020 | 7584 | 0.030 |
Why?
|
Vulnerable Populations | 1 | 2020 | 703 | 0.030 |
Why?
|
Treatment Outcome | 5 | 2020 | 64651 | 0.030 |
Why?
|
Exons | 1 | 2021 | 2393 | 0.030 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2016 | 322 | 0.030 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2016 | 343 | 0.030 |
Why?
|
Postoperative Period | 1 | 2019 | 1815 | 0.030 |
Why?
|
Th17 Cells | 1 | 2021 | 794 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2020 | 1756 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2019 | 1612 | 0.030 |
Why?
|
User-Computer Interface | 1 | 2021 | 1400 | 0.030 |
Why?
|
Linkage Disequilibrium | 1 | 2019 | 2005 | 0.030 |
Why?
|
Adolescent | 2 | 2020 | 88313 | 0.030 |
Why?
|
Biological Transport | 1 | 2018 | 2092 | 0.030 |
Why?
|
Markov Chains | 1 | 2017 | 966 | 0.030 |
Why?
|
Plant Extracts | 1 | 2017 | 498 | 0.030 |
Why?
|
Estrogen Receptor alpha | 1 | 2017 | 582 | 0.030 |
Why?
|
Intraocular Pressure | 1 | 2019 | 1294 | 0.030 |
Why?
|
Cell Death | 1 | 2019 | 1677 | 0.030 |
Why?
|
Young Adult | 1 | 2020 | 59207 | 0.030 |
Why?
|
Phylogeny | 1 | 2020 | 2811 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1793 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2016 | 1706 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1458 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2018 | 1115 | 0.030 |
Why?
|
Logistic Models | 2 | 2018 | 13255 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2019 | 18964 | 0.030 |
Why?
|
Health Status Indicators | 1 | 2018 | 970 | 0.030 |
Why?
|
Nucleic Acid Conformation | 1 | 2016 | 902 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 1743 | 0.030 |
Why?
|
Microsatellite Instability | 1 | 2016 | 716 | 0.030 |
Why?
|
Disease Outbreaks | 1 | 2021 | 1749 | 0.020 |
Why?
|
Europe | 1 | 2019 | 3423 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2017 | 1257 | 0.020 |
Why?
|
Disease Progression | 2 | 2019 | 13502 | 0.020 |
Why?
|
Inhalation Exposure | 1 | 2014 | 431 | 0.020 |
Why?
|
Metabolomics | 1 | 2020 | 1657 | 0.020 |
Why?
|
Lung | 2 | 2021 | 9995 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2019 | 4110 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2021 | 18247 | 0.020 |
Why?
|
Age of Onset | 1 | 2018 | 3304 | 0.020 |
Why?
|
DEAD-box RNA Helicases | 1 | 2013 | 384 | 0.020 |
Why?
|
Survivors | 1 | 2021 | 2371 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2019 | 3602 | 0.020 |
Why?
|
Eating | 1 | 2017 | 1538 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2020 | 2691 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2018 | 3514 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2871 | 0.020 |
Why?
|
Visual Acuity | 1 | 2019 | 2672 | 0.020 |
Why?
|
DNA Repair | 1 | 2019 | 2045 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2020 | 3490 | 0.020 |
Why?
|
Environment | 1 | 2015 | 1122 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2018 | 2455 | 0.020 |
Why?
|
Gastrectomy | 1 | 2014 | 672 | 0.020 |
Why?
|
Internet | 1 | 2021 | 3092 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2900 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2021 | 3061 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2018 | 2057 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2020 | 3702 | 0.020 |
Why?
|
Child | 4 | 2021 | 80162 | 0.020 |
Why?
|
Tumor Burden | 1 | 2014 | 1890 | 0.020 |
Why?
|
Disease Management | 1 | 2019 | 2507 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8832 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 2017 | 1712 | 0.020 |
Why?
|
Haplotypes | 1 | 2014 | 2775 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9330 | 0.020 |
Why?
|
Child, Preschool | 3 | 2016 | 42254 | 0.020 |
Why?
|
Weight Gain | 1 | 2018 | 2347 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2016 | 4638 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 3810 | 0.020 |
Why?
|
Lymphocytes | 1 | 2015 | 2611 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6814 | 0.020 |
Why?
|
Urban Population | 1 | 2015 | 2036 | 0.020 |
Why?
|
Blotting, Western | 1 | 2014 | 5036 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2014 | 6132 | 0.020 |
Why?
|
Heart Rate | 1 | 2018 | 4198 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10766 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11073 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 2898 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2014 | 2824 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2021 | 4811 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2018 | 3201 | 0.010 |
Why?
|
Models, Statistical | 1 | 2018 | 5077 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15838 | 0.010 |
Why?
|
Software | 1 | 2017 | 4434 | 0.010 |
Why?
|
Sex Factors | 1 | 2017 | 10548 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18400 | 0.010 |
Why?
|
Base Sequence | 1 | 2013 | 12450 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2019 | 8999 | 0.010 |
Why?
|
Blood Pressure | 1 | 2018 | 8487 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 2018 | 4876 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2017 | 20093 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2015 | 10203 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2019 | 80582 | 0.010 |
Why?
|
Time Factors | 1 | 2018 | 39975 | 0.010 |
Why?
|
United States | 1 | 2020 | 72339 | 0.010 |
Why?
|